CGT
CLLS

Capital Guardian Trust’s Cellectis CLLS Stock Holding History

Capital Guardian Trust’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-243,691
Closed -$4.47M – 247
2019
Q1 		$4.47M Buy
+243,691
New +$4.32M 0.06% 148

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Guardian Trust's CLLS Position: Q2 2019 in Review

Capital Guardian Trust sold out of Cellectis (CLLS) in Q2 2019, closing a stake of 243,691 shares — an estimated $4.47M sold.

Capital Guardian Trust first reported a position in CLLS in Q1 2019 and held it in 1 quarter. The position peaked at $4.47M in Q1 2019. 70 funds tracked by Wall St. Rank hold CLLS as of Q2 2019.

  • Capital Guardian Trust reported no remaining Cellectis position as of Q2 2019 after selling out during the quarter.
  • Capital Guardian Trust sold 243,691 Cellectis shares in Q2 2019, an estimated $4.47M.
  • Capital Guardian Trust first reported a position in Cellectis in Q1 2019 and held it in 1 quarter.
  • Capital Guardian Trust's Cellectis position peaked at $4.47M in Q1 2019.
  • 70 funds tracked by Wall St. Rank held Cellectis as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.